Summary Safety Review - Clozapine - Assessing the effectiveness of monitoring for low numbers of white blood cells
Clozapine is a prescription drug authorized for sale in Canada to manage symptoms of schizophrenia when other drugs have not helped. Clozapine was developed in the 1960s. In 1975, clozapine was removed from the Canadian market because of reports of life-threatening infections and deaths linked...
Organization:
Health Canada
Resource Formats:
- HTML